ScholarIQanswers from OpenAlex & ORCID
Khrista Boylan
ResearcherPublications, citations & collaboration network
Khrista Boylan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Khrista Boylan have?
ScholarIQindexed works
Khrista Boylan has 198 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Khrista Boylan have?
ScholarIQcitation count
Khrista Boylan has 24,214 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Khrista Boylan?
ScholarIQh-index
Khrista Boylan has an h-index of 65 in OpenAlex.
What is the i10-index of Khrista Boylan?
ScholarIQi10-index
Khrista Boylan has an i10-index of 120 in OpenAlex.
What is the ORCID of Khrista Boylan?
ScholarIQorcid
The ORCID for Khrista Boylan is on the source record.
What is the OpenAlex record for Khrista Boylan?
ScholarIQopenalex
The OpenAlex for Khrista Boylan is on the source record.
What are the most-cited papers on Khrista Boylan?
ScholarIQmost cited works
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus‐Hernandez, Ian R. Mackenzie, Bradley F. Boeve, Adam L. Boxer, Matt Baker, Nicola J. Rutherford, Alexandra M. Nicholson, NiCole A. Finch, Heather C. Flynn, Jennifer Adamson, Naomi Kouri, Aleksandra Wojtas, Pheth Sengdy, Ging‐Yuek Robin Hsiung, Anna Karydas, William W. Seeley, Keith A. Josephs, Giovanni Coppola, Daniel H. Geschwind, Zbigniew K. Wszołek, Howard Feldman, David S. Knopman, Ronald C. Petersen, Bruce L. Miller, Dennis W. Dickson, Khrista Boylan, Neill R. Graff‐Radford, Rosa Rademakers
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS
Hong Joo Kim, Nam Chul Kim, Yong‐Dong Wang, Emily A. Scarborough, Jennifer C. Moore, Zamia Diaz, Kyle S. MacLea, Brian D. Freibaum, Songqing Li, Amandine Molliex, Anderson Kanagaraj, Robert Carter, Khrista Boylan, Aleksandra Wojtas, Rosa Rademakers, Jack L. Pinkus, Steven A. Greenberg, John Q. Trojanowski, Bryan J. Traynor, Bradley Smith, Simon Topp, Athina-Soragia Gkazi, Jack W. Miller, Christopher E. Shaw, Michael Kottlors, Janbernd Kirschner, Alan Pestronk, Yun R. Li, Alice F. Ford, Aaron D. Gitler, Michael Benatar, Oliver D. King, Virginia Kimonis, Eric D. Ross, Conrad C. Weihl, James Shorter, J. Paul Taylor
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H Gordon, Dan H. Moore, Robert G. Miller, Julaine Florence, Joseph L. Verheijde, Carolyn Doorish, Joan F. Hilton, G. Mark Spitalny, Robert B. MacArthur, Hiroshi Mitsumoto, Hans E. Neville, Khrista Boylan, Tahseen Mozaffar, Jerry M. Belsh, John Ravits, Richard Bedlack, Michael C. Graves, Leo McCluskey, Richard J. Barohn, Rup Tandan
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis
Kevin P. Kenna, Perry T.C. van Doormaal, Annelot M. Dekker, Nicola Ticozzi, Brendan Kenna, Frank P. Diekstra, Wouter van Rheenen, Kristel R. van Eijk, Ashley R Jones, Pamela Keagle, Aleksey Shatunov, William Sproviero, Bradley Smith, Michael A. van Es, Simon Topp, Aoife Kenna, Jack W. Miller, Claudia Fallini, Cinzia Tiloca, Russell L. McLaughlin, Caroline Vance, Claire Troakes, Claudia Colombrita, Gabriele Mora, Andrea Calvo, Federico Verde, Safa Al‐Sarraj, Andrew King, Daniela Calini, Jacqueline de Belleroche, Frank Baas, Anneke J. van der Kooi, Marianne de Visser, Anneloor L.M.A. ten Asbroek, Peter C. Sapp, Diane McKenna‐Yasek, Meraida Polak, Seneshaw Asress, José Luís Muñoz-Blanco, Tim M. Strom, Thomas Meitinger, Karen Morrison, Giuseppe Lauria, Kelly L. Williams, P. Nigel Leigh, Garth A. Nicholson, Ian P. Blair, Claire S. Leblond, Patrick A. Dion, Guy A. Rouleau, Hardev Pall, Pamela J. Shaw, Martin R. Turner, Kevin Talbot, Franco Taroni, Khrista Boylan, Marka van Blitterswijk, Rosa Rademakers, Jesús Esteban‐Pérez, Alberto García‐Redondo, Phillip Van Damme, Wim Robberecht, Adriano Chiò, Cinzia Gellera, Carsten Drepper, Michael Sendtner, Antonia Ratti, Jonathan D. Glass, Jesús S. Mora, Nazlı Başak, Orla Hardiman, Albert C. Ludolph, Peter M. Andersen, Jochen H. Weishaupt, Robert H. Brown, Ammar Al‐Chalabi, Vincenzo Silani, Christopher E. Shaw, Leonard H. van den Berg, Jan H. Veldink, John E. Landers
Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i> -associated amyotrophic lateral sclerosis
Tania F. Gendron, Jeannie Chew, Jeannette N. Stankowski, Lindsey R. Hayes, Yong‐Jie Zhang, Mercedes Prudencio, Yari Carlomagno, Lillian M. Daughrity, Karen Jansen‐West, Emilie A. Perkerson, Aliesha D. O’Raw, Casey Cook, Luc Pregent, Véronique Belzil, Marka van Blitterswijk, Lilia J. Tabassian, Chris W. Lee, Mei Yue, Jimei Tong, Yuping Song, Monica Castanedes‐Casey, Linda Rousseau, Virginia Phillips, Dennis W. Dickson, Rosa Rademakers, John Denis Fryer, Beth Rush, Otto Pedraza, Ana M. Caputo, Pamela Desaro, Carla Palmucci, A. Robertson, Michael G. Heckman, Nancy N. Diehl, Edythe Wiggs, Michael Tierney, Laura Braun, Jennifer Farren, David Lacomis, Shafeeq Ladha, Christina Fournier, Leo McCluskey, Lauren Elman, Jon B. Toledo, Jennifer D. McBride, Cinzia Tiloca, Claudia Morelli, Barbara Poletti, Federica Solca, A. Prelle, Joanne Wuu, Jennifer Jockel‐Balsarotti, Frank Rigo, Christine Ambrose, Abhishek Datta, Weixing Yang, Denitza Raitcheva, Giovanna Antognetti, Alexander McCampbell, John C. van Swieten, Bruce L. Miller, Adam L. Boxer, Robert H. Brown, Robert Bowser, Timothy M. Miller, John Q. Trojanowski, Murray Grossman, James D. Berry, William T. Hu, Antonia Ratti, Bryan J. Traynor, Matthew D. Disney, Michael Benatar, Vincenzo Silani, Jonathan D. Glass, Mary Kay Floeter, Jeffrey D. Rothstein, Khrista Boylan, Leonard Petrucelli